skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

316 studies were found about ( Kaletra OR lopinavir AND ritonavir )

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Condition: HIV; AIDS; Lopinavir; Treatment Failure

NCT ID: NCT01189695

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Condition: Antiretroviral Therapy in HIV-1 Infected Children

NCT ID: NCT01196195

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00400738

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Condition: HIV Infection; Pregnancy; Breastfeeding; HIV Infections

NCT ID: NCT00936195

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Condition: HIV Infection

NCT ID: NCT00420355

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Condition: HIV Infections

NCT ID: NCT00004583

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Condition: HIV Infections

NCT ID: NCT00424814

GW873140 In Combination With Kaletra In HIV Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00102778

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

Condition: HIV Infection

NCT ID: NCT00114933

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00654147

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00752037

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Condition: HIV Infections

NCT ID: NCT00038480

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00004581

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Condition: HIV Infection

NCT ID: NCT00234975

Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Condition: HIV Infections

NCT ID: NCT00665951

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00004578

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Condition: HIV Infections

NCT ID: NCT00025727

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Condition: HIV Infections

NCT ID: NCT00116636

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00234910

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Condition: HIV Infections

NCT ID: NCT00640263

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Condition: HIV-1 Infection

NCT ID: NCT01139905

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00140751

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Condition: HIV Infections

NCT ID: NCT00038532

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Condition: HIV Infections

NCT ID: NCT00196625

Induction-Maintenance of Lopinavir/r in HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00159224

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Lopinavir/Ritonavir (Kaletra) PK in Children

Condition: HIV/AIDS Treatment; HIV Infections

NCT ID: NCT00810108

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

Condition: HIV Infections

NCT ID: NCT00508222

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00028366

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00105079

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Condition: HIV Infections

NCT ID: NCT00046033

Steady State PK in Malnourished HIV Infected Children

Condition: HIV Positive; Malnourished

NCT ID: NCT01818258

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Condition: HIV Infection

NCT ID: NCT00234962

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00004580

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Condition: HIV Infections

NCT ID: NCT00038636

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00038519

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00038220

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00184951

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Condition: HIV Infection

NCT ID: NCT01533272

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00179335

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Condition: HIV Infection

NCT ID: NCT01576731

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Condition: HIV Infection

NCT ID: NCT01237444

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Condition: HIV Infections

NCT ID: NCT00102986

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Condition: HIV Infections

NCT ID: NCT00632970

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00075231

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00981318

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Condition: HIV Infections

NCT ID: NCT00885664

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Condition: HIV Infections

NCT ID: NCT00043966

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients

Condition: HIV Infections

NCT ID: NCT00661349

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Condition: HIV Infections

NCT ID: NCT00109590

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00388492

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Condition: HIV Infection

NCT ID: NCT00443703

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00121017

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Condition: HIV Infections

NCT ID: NCT00084058

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Condition: HIV Infections; Pregnancy

NCT ID: NCT00125983

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT01516970

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00023218

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00085943

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Condition: HIV Infection

NCT ID: NCT01159743

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT00827112

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Condition: HIV-1 Infections

NCT ID: NCT01074931

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Condition: HIV Infections; Malaria

NCT ID: NCT00869700

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT02097381

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

Condition: HIV Infections; Pregnancy

NCT ID: NCT00409591

Treatment Options for Protease Inhibitor-exposed Children

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT01146873

HIV - Monotherapy in Switzerland (MOST-ch)

Condition: HIV Infections

NCT ID: NCT00531986

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

Condition: HIV Infection

NCT ID: NCT00443729

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT00775606

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

Condition: HIV Infections

NCT ID: NCT00532168

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

Condition: HIV Infections

NCT ID: NCT00004582

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

Condition: HIV Infection

NCT ID: NCT00386659

Dose Reduction of Lopinavir in Children

Condition: HIV Infections

NCT ID: NCT00887120

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Condition: HIV Infections; Malaria

NCT ID: NCT00266058

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Condition: HIV-1

NCT ID: NCT00144833

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Condition: HIV Infections

NCT ID: NCT00762320

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00605098

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Condition: HIV Infections

NCT ID: NCT00573001

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa

Condition: HIV

NCT ID: NCT01088516

Lopinavir Capsules to Kaletra or Invirase Tablets

Condition: HIV Infections

NCT ID: NCT00438152

Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

Condition: HIV Infection

NCT ID: NCT00200369

Kaletra-isentress Treatment Evaluation

Condition: HIV Infections

NCT ID: NCT00700115

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Condition: HIV Infections

NCT ID: NCT00052117

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)

Condition: HIV-infected Children

NCT ID: NCT01307124

Depot Contraception With and Without Lopinavir/Ritonavir

Condition: HIV Infection

NCT ID: NCT01231451

RAltegravir Switch STudy: Effects on Endothelial Recovery

Condition: HIV Infection; Endothelial Dysfunction

NCT ID: NCT01453933

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00945282

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00262522

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Condition: HIV

NCT ID: NCT01445223

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Condition: HIV Infections

NCT ID: NCT00335686

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Condition: HIV Infections

NCT ID: NCT00044837

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00358917

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Condition: HIV Infections

NCT ID: NCT00145795

Lopinavir (LPV) Dose Reduction

Condition: HIV-1 Infections

NCT ID: NCT01159275

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Condition: HIV Infections

NCT ID: NCT00135395

HIV Antiretroviral Drugs and Metabolism

Condition: HIV Infections

NCT ID: NCT00525239

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

Condition: HIV Infections

NCT ID: NCT00357552

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Condition: HIV; AIDS

NCT ID: NCT00247143

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

Condition: HIV

NCT ID: NCT00344487

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01738555

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Condition: HIV Infections

NCT ID: NCT00621166

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)

Condition: HIV Infections

NCT ID: NCT02116660

Intense Acute Infection Study

Condition: Acute HIV Infection

NCT ID: NCT01154673

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00414518

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00056641

Raltegravir Insulin Sensitivity Study

Condition: HIV Infections

NCT ID: NCT00531999

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa

Condition: HIV Infection

NCT ID: NCT01905059

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00608569

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Condition: HIV; Pregnancy

NCT ID: NCT01854762

Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women

Condition: HIV-1 Infection

NCT ID: NCT01296152

A PK and Salvage Study for Children With HIV-infection

Condition: HIV Infections

NCT ID: NCT00476359

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004855

Europe-Africa Research Network for Evaluation of Second-line Therapy

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT00988039

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00985543

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Condition: HIV Infections

NCT ID: NCT00017992

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00307151

Study of Anti-HIV Therapy Intensification

Condition: HIV Infections

NCT ID: NCT00034086

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)

Condition: HIV Infections

NCT ID: NCT00571961

Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy

Condition: HIV

NCT ID: NCT01116817

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Condition: HIV Infections

NCT ID: NCT00759070

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Condition: HIV Infections

NCT ID: NCT00884793

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Condition: HIV Infections

NCT ID: NCT00028301

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Condition: HIV Infections

NCT ID: NCT01068873

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT01049685

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

Condition: HIV Infections

NCT ID: NCT00994344

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Condition: HIV Infections

NCT ID: NCT00413153

Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected

Condition: HIV-1 Infection; Pf Subclinical Parasitemia

NCT ID: NCT01632891

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00752856

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Ritonavir-boosted Lopinavir Monotherapy

Condition: HIV

NCT ID: NCT01002898

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT00711009

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir

Condition: HIV Infections

NCT ID: NCT01294761

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Kaletra Sex/Gender Pharmacokinetics (PK) Study

Condition: HIV Infections

NCT ID: NCT00148759

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Condition: HIV Infections

NCT ID: NCT00414284

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01328158

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Condition: HIV Infections

NCT ID: NCT00627055

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Condition: HIV Infections; Lipodystrophy; Wasting Disease

NCT ID: NCT00028314

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Condition: HIV Infections

NCT ID: NCT00756730

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Condition: HIV Infections; Malaria

NCT ID: NCT00697892

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Condition: HIV Infections

NCT ID: NCT00100646

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Condition: HIV Infections

NCT ID: NCT00036452

Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations

Condition: HIV Infection; AIDS

NCT ID: NCT00347750

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Condition: HIV; Hepatitis C; Liver Fibrosis

NCT ID: NCT01231685

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Condition: HIV-1

NCT ID: NCT00772902

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Condition: HIV Infections

NCT ID: NCT00099632

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Condition: HIV Transmission; HIV Infections

NCT ID: NCT00949234

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

Condition: HIV Infections

NCT ID: NCT01045369

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01383005

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00090779

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

Condition: HIV Infection

NCT ID: NCT00281606

TDM of Generic Lopinavir/Ritonavir 200/50 mg

Condition: HIV

NCT ID: NCT00802334

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00771498

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT00100984

Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

Condition: HIV Infections

NCT ID: NCT00977756

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

NRTI-Sparing Pilot Study

Condition: HIV; Mitochondrial Toxicity

NCT ID: NCT00143689

Lopinavir/Ritonavir Monotherapy in Children

Condition: HIV Infections

NCT ID: NCT00626301

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

Condition: HIV Infection

NCT ID: NCT01166477

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Condition: Drug Interactions; Human Immunodeficiency Virus

NCT ID: NCT01227590

Anti-Retrovirals for Kaposi's Sarcoma

Condition: Kaposi's Sarcoma; HIV Infections

NCT ID: NCT00444379

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Condition: HIV Infections

NCT ID: NCT00144105

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

Condition: Tuberculosis; HIV

NCT ID: NCT00828529

Evaluation of Kaletra Therapy Over the Long-term

Condition: Human Immunodeficiency Virus

NCT ID: NCT01083810

Drug Use Investigation of Kaletra

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076972

Special Investigation of Kaletra in Pregnant Women

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076985

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

GSK706769/KALETRA Drug-drug Interaction Study

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00723775

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00027339

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)

Condition: HIV Infection

NCT ID: NCT01103596

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Condition: HIV

NCT ID: NCT01581853

Kaletra in Combination With Antiretroviral Agents

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076179

A Study of HIV-Disease Development in Aging

Condition: HIV Infections

NCT ID: NCT00006144

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

Condition: HIV

NCT ID: NCT00767117

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Condition: HIV; Fenofibrate; Protease Inhibitors; Hypertriglyceridemia; Glucuronosyltransferase

NCT ID: NCT01148004

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

Relationship Between HIV-1 Subtype and ARV Response

Condition: HIV Infections

NCT ID: NCT00585793

Kaletra: Therapy With Double Protease Inhibitors

Condition: Human Immunodeficiency Virus

NCT ID: NCT01075191

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122590

NNRTI/PI Toxicity Switch to Darunavir Study

Condition: HIV

NCT ID: NCT00765154

A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

Condition: HIV Infection

NCT ID: NCT00785616

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Surveillance of Kaletra in Korean Patients

Condition: HIV-1 Infection

NCT ID: NCT01083173

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Condition: HIV-1 Patients

NCT ID: NCT01379703

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Condition: Human Immunodeficiency Virus-Infection

NCT ID: NCT01153269

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Condition: AIDS; Tuberculosis

NCT ID: NCT01700790

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Condition: HIV Infections

NCT ID: NCT00160849

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Condition: HIV Infections

NCT ID: NCT00135434

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Condition: Human Immunodeficiency Virus

NCT ID: NCT00648999

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00162643

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Condition: HIV Infections; AIDS-Related Opportunistic Infections

NCT ID: NCT00055120

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Condition: Human Immunodeficiency Virus

NCT ID: NCT01097655

A Study of HIV Levels During Pregnancy and After Childbirth

Condition: HIV Infections; Pregnancy

NCT ID: NCT00041964

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00920088

GSK1349572 Drug Interaction Study With Protease Inhibitors

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00774735

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Condition: HIV Infections; Malaria

NCT ID: NCT00719602

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

Condition: HIV Infections

NCT ID: NCT00089505

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01662336

Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children

Condition: HIV

NCT ID: NCT01172535

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Post-Exposure Prophylaxis in Health Care Workers

Condition: Human Immunodeficiency Virus

NCT ID: NCT01234116

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

Condition: Pregnancy; HIV

NCT ID: NCT00766818

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00120393

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

Condition: Healthy; Pharmacokinetics

NCT ID: NCT00176033

Bone and Body Comp: A Sub Study of the SECOND-LINE Study

Condition: HIV

NCT ID: NCT01513122

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01737359

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Condition: Endothelial Dysfunction

NCT ID: NCT00720590

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

Condition: Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00836212

Early HIV Therapy in Patients With High CD4 Cell Counts

Condition: HIV

NCT ID: NCT01479634

Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors

Condition: HIV-1 Infection

NCT ID: NCT01480713

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Condition: HIV Infection

NCT ID: NCT00110877

A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort

Condition: HIV-1; AIDS

NCT ID: NCT00268827

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Condition: HIV

NCT ID: NCT00258557

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

Condition: HIV Infections

NCT ID: NCT00148785

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

Condition: HIV

NCT ID: NCT00335192

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

Condition: HIV Seropositivity

NCT ID: NCT01174914

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Condition: HIV Infections

NCT ID: NCT00294372

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Condition: HIV; Hypercholesterolemia; Dyslipidemia

NCT ID: NCT01705873

HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00043641

Two Part Study to Study Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir (EVG) Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Subjects

Condition: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections

NCT ID: NCT01923311

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00411957

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

Condition: HIV

NCT ID: NCT01671982

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

Condition: HIV Infections

NCT ID: NCT00312754

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Condition: HIV Infections

NCT ID: NCT00642291

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050908

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Condition: Diabetes; HIV Infections; Insulin Resistance

NCT ID: NCT00259727

ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir

Condition: HIV

NCT ID: NCT02102048

Comparative Tolerability of Protease Inhibitors

Condition: HIV

NCT ID: NCT01450618

Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men

Condition: HIV Infection; Cardiovascular Risk; HIV Infections

NCT ID: NCT00846599

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

Condition: HIV Infections; Malaria

NCT ID: NCT00421473

Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs

Condition: HIV Infection

NCT ID: NCT01543035

Antihyperlipidemic Effects of Oyster Mushrooms

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00069524

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00708162

Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Condition: ADHD; HIV

NCT ID: NCT01232361

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

Condition: HIV Infections

NCT ID: NCT00658346

Antimalarial Pharmacology in Children and Pregnant Women in Uganda

Condition: Malaria; HIV

NCT ID: NCT01717885

Fosamprenavir in Pts With Hepatic Impairment

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01054586

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Condition: HIV; HIV Infections

NCT ID: NCT00966329

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Condition: HIV Infections

NCT ID: NCT00031044

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

Condition: HIV Infections

NCT ID: NCT00773708

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Condition: Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID

NCT ID: NCT00476983

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Condition: HIV Infections

NCT ID: NCT00753324

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Condition: HIV-1

NCT ID: NCT00665847

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01814722

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Condition: Healthy Volunteers

NCT ID: NCT00474201

The Effect of Lopinavir/Ritonavir on Endothelial Function

Condition: Healthy

NCT ID: NCT00076414

GSK706769 A First Time in Human Study For Males and Females

Condition: Healthy Subjects

NCT ID: NCT00539201